Study of Fibrinogen Metabolism During Severe Trauma and Burns
Alteration in Fibrinogen Metabolism in Patients With Severe Burns and Traumatic Injuries
1 other identifier
observational
30
0 countries
N/A
Brief Summary
To study the fibrinogen metabolic changes in relation to coagulation disorder in patients with severe burns and trauma injuries. As a result of the burn or trauma injury breakdown of fibrinogen is accelerated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2005
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2005
CompletedFirst Submitted
Initial submission to the registry
December 25, 2007
CompletedFirst Posted
Study publicly available on registry
January 9, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedFebruary 4, 2015
February 1, 2015
8.9 years
December 25, 2007
February 2, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
During the flow phase following burn or trauma injury, fibrinogen degradation is accelerated
7
Secondary Outcomes (1)
Fibrinogen degradation stimulates fibrinogen synthesis at the expense of whole body protein catabolism
7 days
Study Arms (3)
Healthy Volunteers
Healthy Volunteers
Burn patients
Patients who have sustained burn injury greater than or equal to 20% of total body surface area
Trauma patients
Patients who have undergone trauma
Eligibility Criteria
Burn patients Trauma patients Healthy Volunteers
You may qualify if:
- % total body surface area burn or more
- severe trauma with injury severity score greater than 10
- between ages of 18 and 65 years
You may not qualify if:
- history of blood clotting disorder
- history of liver disease such as cirrhosis or hepatitis
- pregnant or nursing
- allergic to iodine, shellfish or dye used in X-Rays
- taking long term medications for blood clotting usch as Coumadin or Plavix
- prisoners
- receiving total parenteral nutrition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Zuckerman L, Caprini JA, Lipp V, Vagher JP. Disseminated intravascular multiple systems activation (DIMSA) following thermal injury. J Trauma. 1978 Jun;18(6):432-9. doi: 10.1097/00005373-197806000-00008.
PMID: 660699BACKGROUND
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Wenjun Z Martini, PhD
United States Army Institute of Surgical Research
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 25, 2007
First Posted
January 9, 2008
Study Start
February 1, 2005
Primary Completion
January 1, 2014
Study Completion
January 1, 2014
Last Updated
February 4, 2015
Record last verified: 2015-02